A novel bioadhesive intranasal delivery system for inactivated influenza vaccines
Authors:
- Maylene BrionesMBMaylene Briones
- Derek T. O’hAganDODerek T. O’hAgan
- 1 February 2001
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 70 (3) , 267-276
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The adjuvant effect of a non‐toxic mutant of heat‐labile enterotoxin of Escherichia coli for the induction of measles virus‐specific CTL responses after intranasal co‐immunization with a synthetic peptideImmunology, 1996
- Evaluation of Cold-Adapted, Reassortant Influenza B Virus Vaccines in Elderly and Chronically III AdultsThe Journal of Infectious Diseases, 1994
- Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccineVaccine, 1994
- Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery systemVaccine, 1993
- Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccineEuropean Journal of Immunology, 1992
- Investigation of the nasal absorption of biosynthetic human growth hormone in sheep—use of a bioadhesive microsphere delivery systemInternational Journal of Pharmaceutics, 1990
- Pharmaceutical and Medical Aspects of Bioadhesive Systems for Drug AdministrationDrug Development and Industrial Pharmacy, 1988
- Quantification of haemagglutinin of influenza Tween-ether split vaccines by immunodiffusionVaccine, 1985
- An in-vitro investigation of mucosa-adhesive materials for use in controlled drug deliveryJournal of Pharmacy and Pharmacology, 1984
- Influenza vaccination1983